Speaker :

Dr. Sainath Bhethanabhotla, Medical Oncologist, Hyderabad

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive  Early-stage Breast Cancer From the Phase III ExteNET Trial